{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:57:02Z","timestamp":1792166222808,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ahj.2022.06.002","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T01:57:46Z","timestamp":1655171866000},"page":"42-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Select drug-drug interactions with colchicine and cardiovascular medications: A review"],"prefix":"10.1016","volume":"252","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7560-9521","authenticated-orcid":false,"given":"Dave L.","family":"Dixon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaideep","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowan","family":"Spence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azita H.","family":"Talasaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara S.","family":"Wiggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2022.06.002_bib0001","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bjd.15896","article-title":"Colchicine: an ancient drug with novel applications","volume":"178","author":"Dasgeb","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ahj.2022.06.002_bib0002","doi-asserted-by":"crossref","first-page":"e13464","DOI":"10.1111\/eci.13464","article-title":"Effect of low-dose colchicine in acute and chronic coronary syndromes: a systematic review and meta-analysis","volume":"51","author":"Aimo","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ahj.2022.06.002_bib0003","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jacc.2019.11.021","article-title":"Management of acute and recurrent pericarditis: JACC state-of-the-Art review","volume":"75","author":"Chiabrando","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2022.06.002_bib0004","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.jacc.2013.08.726","article-title":"Colchicine and the heart: pushing the envelope","volume":"62","author":"Deftereos","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2022.06.002_bib0005","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-155-7-201110040-00359","article-title":"Colchicine for recurrent pericarditis (CORP): a randomized trial","volume":"155","author":"Imazio","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2022.06.002_bib0006","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.105.542738","article-title":"Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial","volume":"112","author":"Imazio","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2022.06.002_bib0007","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.165.17.1987","article-title":"Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial","volume":"165","author":"Imazio","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2022.06.002_bib0008","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/S0140-6736(13)62709-9","article-title":"Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial","volume":"383","author":"Imazio","year":"2014","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ahj.2022.06.002_bib0009","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa1208536","article-title":"A randomized trial of colchicine for acute pericarditis","volume":"369","author":"Imazio","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2022.06.002_bib0010","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1093\/eurheartj\/ehq319","article-title":"COlchicine for the prevention of the post-pericardiotomy syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial","volume":"31","author":"Imazio","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2022.06.002_bib0011","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.2014.11026","article-title":"Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial","volume":"312","author":"Imazio","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2022.06.002_bib0012","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","volume":"36","author":"Adler","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2022.06.002_bib0013","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2022.06.002_bib0014","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2022.06.002_bib0015","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2022.06.002_bib0016","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2022.06.002_bib0017","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","article-title":"Colchicine in patients with acute coronary syndrome: the Australian COPS randomized clinical trial","volume":"142","author":"Tong","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2022.06.002_bib0018","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clinthera.2018.11.016","article-title":"Why colchicine should be considered for secondary prevention of atherosclerosis: an overview","volume":"41","author":"Nidorf","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.ahj.2022.06.002_bib0019","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021198","article-title":"Colchicine in patients with coronary artery disease: a systematic review and meta-analysis of randomized trials","volume":"10","author":"Kofler","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2022.06.002_bib0020","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.hrthm.2014.02.002","article-title":"Colchicine for prevention of atrial fibrillation recurrence after pulmonary vein isolation: Mid-term efficacy and effect on quality of life","volume":"11","author":"Deftereos","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ahj.2022.06.002_bib0021","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1161\/CIRCULATIONAHA.111.026153","article-title":"Colchicine reduces postoperative atrial fibrillation: results of the colchicine for the prevention of the postpericardiotomy syndrome (COPPS) atrial fibrillation substudy","volume":"124","author":"Imazio","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2022.06.002_bib0022","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/art.30389","article-title":"Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4\/P-glycoprotein inhibitors","volume":"63","author":"Terkeltaub","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ahj.2022.06.002_bib0023","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ahj.2022.06.002_bib0024","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1289\/ehp.929881","article-title":"Human cytochromes P450: evolution and cDNA-directed expression","volume":"98","author":"Gonzalez","year":"1992","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.ahj.2022.06.002_bib0025","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMra032424","article-title":"Drug metabolism and variability among patients in drug response","volume":"352","author":"Wilkinson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2022.06.002_bib0026","doi-asserted-by":"crossref","first-page":"e93261","DOI":"10.1371\/journal.pone.0093261","article-title":"Differential expression of cytochrome P450 enzymes in normal and tumor tissues from childhood rhabdomyosarcoma","volume":"9","author":"Molina-Ortiz","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ahj.2022.06.002_bib0027","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/bj3260539","article-title":"P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain","volume":"326","author":"Beaulieu","year":"1997","journal-title":"Biochem J"},{"key":"10.1016\/j.ahj.2022.06.002_bib0028","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1095\/biolreprod.102.003558","article-title":"Multidrug resistance genes and p-glycoprotein in the testis of the rat, mouse, Guinea pig, and human","volume":"67","author":"Melaine","year":"2002","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ahj.2022.06.002_bib0029","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1128\/AAC.49.4.1626-1628.2005","article-title":"Role of P-glycoprotein in distribution of nelfinavir across the blood-mammary tissue barrier and blood-brain barrier","volume":"49","author":"Edwards","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ahj.2022.06.002_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2006.10.007","article-title":"A primer on the mechanics of P-glycoprotein the multidrug transporter","volume":"55","author":"Hennessy","year":"2007","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ahj.2022.06.002_bib0031","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1161\/CIR.0000000000000456","article-title":"Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American Heart Association","volume":"134","author":"Wiggins","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2022.06.002_bib0032","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/15563650.2010.495348","article-title":"Colchicine poisoning: the dark side of an ancient drug","volume":"48","author":"Finkelstein","year":"2010","journal-title":"Clin Toxicol Phila Pa"},{"key":"10.1016\/j.ahj.2022.06.002_bib0033","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s40256-020-00459-1","article-title":"Gout pharmacotherapy in cardiovascular diseases: a review of utility and outcomes","volume":"21","author":"Kaul","year":"2021","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.ahj.2022.06.002_bib0034","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.semarthrit.2020.11.007","article-title":"A systematic review of the infectious complications of colchicine and the use of colchicine to treat infections","volume":"51","author":"McEwan","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ahj.2022.06.002_bib0035","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/sj.bjp.0703920","article-title":"HMG-CoA reductase inhibitors and P-glycoprotein modulation","volume":"132","author":"Bogman","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ahj.2022.06.002_bib0036","doi-asserted-by":"crossref","DOI":"10.1002\/mus.20135","article-title":"Cytoskeletal myotoxicity from simvastatin and colchicine","volume":"30","author":"Baker","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ahj.2022.06.002_bib0037","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s40261-013-0168-8","article-title":"Effect of steady-state atorvastatin on the pharmacokinetics of a single dose of colchicine in healthy adults under fasted conditions","volume":"34","author":"Davis","year":"2014","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.ahj.2022.06.002_bib0038","unstructured":"Colcrys [Package Insert]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/022351lbl.pdf [accessed 3 June 2021 ]"},{"key":"10.1016\/j.ahj.2022.06.002_bib0039","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2022.06.002_bib0040","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/phar.2074","article-title":"Evolving role of non-statin therapy for the management of dyslipidemia and cardiovascular risk reduction: past, present, and future","volume":"38","author":"Sisson","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ahj.2022.06.002_bib0041","doi-asserted-by":"crossref","first-page":"e20390","DOI":"10.1097\/MD.0000000000020390","article-title":"Fenofibrate monotherapy-induced rhabdomyolysis in a patient with post-pancreatitis diabetes mellitus: a rare case report and a review of the literature","volume":"99","author":"Zhou","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ahj.2022.06.002_bib0042","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1345\/aph.1C028","article-title":"Rhabdomyolysis associated with gemfibrozil-colchicine therapy","volume":"36","author":"Atmaca","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ahj.2022.06.002_bib0043","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1472-8206.2006.00408.x","article-title":"Characterization of beta-adrenoceptor antagonists as substrates and inhibitors of the drug transporter P-glycoprotein1","volume":"20","author":"Bachmakov","year":"2006","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.ahj.2022.06.002_bib0044","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1349-7006.2003.tb01356.x","article-title":"Effects of carvedilol on MDR1 -mediated multidrug resistance: comparison with verapamil","volume":"94","author":"Kakumoto","year":"2003","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ahj.2022.06.002_bib0045","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.dmpk.2016.08.007","article-title":"Application of substrate depletion assay to evaluation of CYP isoforms responsible for stereoselective metabolism of carvedilol","volume":"31","author":"Iwaki","year":"2016","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.ahj.2022.06.002_bib0046","unstructured":"Gloperba [Package Insert]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/210942s000lbl.pdf [accessed 3 June 2021]."},{"key":"10.1016\/j.ahj.2022.06.002_bib0047","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/phar.1697","article-title":"Effectiveness of Pharmacist-Led amiodarone monitoring services on improving adherence to amiodarone monitoring recommendations: a systematic review","volume":"36","author":"Dixon","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ahj.2022.06.002_bib0048","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1124\/dmd.115.065623","article-title":"P450-Based drug-drug interactions of amiodarone and its metabolites: diversity of inhibitory mechanisms","volume":"43","author":"McDonald","year":"2015","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.ahj.2022.06.002_bib0049","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1186\/1757-1626-2-6602","article-title":"Patient risk factors and adverse drug interactions in the treatment of acute gouty arthritis in the elderly: a case report","volume":"2","author":"Zagler","year":"2009","journal-title":"Cases J"},{"issue":"25","key":"10.1016\/j.ahj.2022.06.002_bib0050","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.jacc.2013.02.058","article-title":"The P-glycoprotein transport system and cardiovascular drugs","volume":"61","author":"Wessler","year":"2013","journal-title":"J Am Coll Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870322001260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870322001260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:08:49Z","timestamp":1757570929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870322001260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":50,"alternative-id":["S0002870322001260"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2022.06.002","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Select drug-drug interactions with colchicine and cardiovascular medications: A review","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2022.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}